artesunic acid has been researched along with Colitis Gravis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Li, L; Liu, M; Tao, Y; Wei, S; Yang, H; Yin, S | 1 |
| Chen, Q; Lin, JD; Qiu, LZ; Yang, ZB | 1 |
| Chen, YX; Dou, XT; Huang, SL; Liu, WJ; Xie, Y; Yu, CG; Zhang, XQ; Zou, XP | 1 |
3 other study(ies) available for artesunic acid and Colitis Gravis
| Article | Year |
|---|---|
Artesunate ameliorates DSS-induced ulcerative colitis by protecting intestinal barrier and inhibiting inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Artesunate; Colitis, Ulcerative; Dextran Sulfate; Female; Inflammation Mediators; Intestinal Mucosa; Mice; Mice, Inbred ICR | 2020 |
Artesunate alleviates the inflammatory response of ulcerative colitis by regulating the expression of miR-155.
Topics: Animals; Anti-Inflammatory Agents; Artesunate; Colitis, Ulcerative; Dose-Response Relationship, Drug; Gene Expression; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; MicroRNAs; RAW 264.7 Cells | 2021 |
Artesunate exerts protective effects against ulcerative colitis via suppressing Toll‑like receptor 4 and its downstream nuclear factor‑κB signaling pathways.
Topics: Animals; Artesunate; Cell Movement; Cell Survival; Colitis, Ulcerative; Colon; Dextran Sulfate; Hemoglobins; Inflammation Mediators; Macrophages; Male; Mice; NF-kappa B; Peroxidase; Protective Agents; Rats, Sprague-Dawley; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4 | 2019 |